NeoPharm CO., LTD. (KOSDAQ: 092730)

NeoPharm CO., LTD. Balance Sheet

Financials in millions KRW. Fiscal year is January - December.

Fiscal Year	TTM	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019
Period Ending	Jun 30, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019
Cash & Equivalents	15,334	11,881	10,883	7,049	11,189	5,515
Short-Term Investments	92,724	98,026	102,000	98,000	84,000	80,000
Trading Asset Securities	2,106	2,083	602.5	-	992.06	-
Cash & Short-Term Investments	110,164	111,990	113,485	105,049	96,181	85,515
Cash Growth	-6.56%	-1.32%	8.03%	9.22%	12.47%	101.58%
Accounts Receivable	12,527	8,555	6,543	7,513	8,322	8,903
Other Receivables	1,681	1,809	1,103	514.09	527.14	611.62
Receivables	14,214	10,383	7,665	8,045	8,863	9,526
Inventory	13,016	10,195	8,749	7,973	8,090	5,840
Prepaid Expenses	755.67	461.05	61.34	66.55	259.57	38.53
Other Current Assets	888.31	1,474	1,309	349.62	158.57	759.97
Total Current Assets	139,038	134,502	131,270	121,484	113,551	101,680
Property, Plant & Equipment	29,490	29,244	9,341	9,743	10,121	10,496
Long-Term Investments	4,812	4,684	6,369	3,559	647.85	1,649
Other Intangible Assets	2,073	2,237	1,786	2,055	2,380	2,384
Long-Term Deferred Tax Assets	153	436.34	135.32	171.21	375.56	595.83
Other Long-Term Assets	6,215	6,220	6,328	6,280	5,786	5,848
Total Assets	181,923	177,459	155,347	143,408	132,978	122,742
Accounts Payable	7,483	6,435	3,703	4,347	4,194	3,174
Accrued Expenses	-	-	-	-	1.06	2.58
Short-Term Debt	-	-	-	-	-	400
Current Portion of Long-Term Debt	-	17.68	18.59	19.27	4,020	19.94
Current Portion of Leases	616.22	617.57	393.58	437.71	270.65	256.34
Current Income Taxes Payable	2,638	3,876	3,778	3,145	2,291	2,596
Current Unearned Revenue	2.33	2.24	-	-	-	-
Other Current Liabilities	4,836	5,997	5,244	4,992	4,100	6,383
Total Current Liabilities	15,575	16,945	13,137	12,941	14,877	12,831
Long-Term Debt	-	-	-	-	-	4,000
Long-Term Leases	196.01	430.05	-	101.79	19.37	-
Other Long-Term Liabilities	67.63	57.73	-	0	0	0
Total Liabilities	15,839	17,433	13,137	13,103	15,260	17,049
Common Stock	4,104	4,104	4,104	4,104	4,104	4,104
Additional Paid-In Capital	45,170	45,170	45,170	45,170	45,133	44,619
Retained Earnings	119,634	113,603	96,106	83,848	71,100	59,085
Treasury Stock	-2,679	-2,679	-2,679	-2,679	-2,679	-2,679
Comprensive Income & Other	-144.63	-171.99	-490.33	-138.2	59.47	563.9
Shareholders' Equity	166,084	160,026	142,211	130,305	117,718	105,693
Total Liabilities & Equity	181,923	177,459	155,347	143,408	132,978	122,742
Total Debt	812.24	1,065	412.16	558.77	4,310	4,676
Net Cash (Debt)	109,351	110,925	113,073	104,490	91,871	80,839
Net Cash Growth	-7.13%	-1.90%	8.21%	13.74%	13.65%	92.52%
Net Cash Per Share	13983.47	14183.61	14458.33	13360.85	11636.25	10687.21
Filing Date Shares Outstanding	7.82	7.82	7.82	7.82	7.82	7.82
Total Common Shares Outstanding	7.82	7.82	7.82	7.82	7.82	7.82
Working Capital	123,462	117,558	118,133	108,543	98,675	88,849
Book Value Per Share	21231.47	20462.03	18184.06	16661.70	15052.19	13514.59
Tangible Book Value	164,011	157,789	140,424	128,250	115,337	103,309
Tangible Book Value Per Share	20966.43	20176.01	17955.63	16398.92	14747.81	13209.76
Land	8,554	8,554	1,202	1,223	1,286	1,286
Buildings	20,197	18,345	9,791	9,881	10,248	10,229
Machinery	8,977	8,214	6,086	6,043	5,798	5,710
Construction In Progress	74.85	1,686	-	-	-	-

Source: S&P Capital IQ. Standard template. Financial Sources.